Davis AA - Search Results

1

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.

Jackson SA, Davis AA, Li J, Yi N, McCormick SR, Grant C, Fallen T, Crawford B, Loranger K, Litton J, Arun B, Vande Wydeven K, Sidani A, Farmer K, Sanders M, Hoskins K, Nussbaum R, Esserman L, Garber JE, Kaklamani VG; Northwestern Cancer Genetics Group. Jackson SA, et al. Among authors: davis aa. Cancer. 2014 May 15;120(10):1557-64. doi: 10.1002/cncr.28577. Epub 2014 Feb 12. Cancer. 2014. PMID: 24522996 Free article.

2

Metabolic syndrome and triple-negative breast cancer: a new paradigm.

Davis AA, Kaklamani VG. Davis AA, et al. Int J Breast Cancer. 2012;2012:809291. doi: 10.1155/2012/809291. Epub 2011 Oct 15. Int J Breast Cancer. 2012. PMID: 22295251 Free PMC article.

3

Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer.

Chae YK, Davis AA, Jain S, Santa-Maria C, Flaum L, Beaubier N, Platanias LC, Gradishar W, Giles FJ, Cristofanilli M. Chae YK, et al. Among authors: davis aa. Mol Cancer Ther. 2017 Jul;16(7):1412-1420. doi: 10.1158/1535-7163.MCT-17-0061. Epub 2017 Apr 26. Mol Cancer Ther. 2017. PMID: 28446639

4

Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.

Chae YK, Davis AA, Raparia K, Agte S, Pan A, Mohindra N, Villaflor V, Giles F. Chae YK, et al. Among authors: davis aa. Clin Lung Cancer. 2019 Mar;20(2):88-96.e6. doi: 10.1016/j.cllc.2018.09.008. Epub 2018 Sep 25. Clin Lung Cancer. 2019. PMID: 30425022

5

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors.

Davis AA, Patel VG. Davis AA, et al. J Immunother Cancer. 2019 Oct 26;7(1):278. doi: 10.1186/s40425-019-0768-9. J Immunother Cancer. 2019. PMID: 31655605 Free PMC article.

6

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.

Davis AA, Zhang Q, Gerratana L, Shah AN, Zhan Y, Qiang W, Finkelman BS, Flaum L, Behdad A, Gradishar WJ, Platanias LC, Cristofanilli M. Davis AA, et al. Breast Cancer Res. 2019 Dec 4;21(1):137. doi: 10.1186/s13058-019-1229-6. Breast Cancer Res. 2019. PMID: 31801599 Free PMC article.

7

Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.

Gerratana L, Davis AA, Polano M, Zhang Q, Shah AN, Lin C, Basile D, Toffoli G, Wehbe F, Puglisi F, Behdad A, Platanias LC, Gradishar WJ, Cristofanilli M. Gerratana L, et al. Among authors: davis aa. Eur J Cancer. 2021 Jan;143:147-157. doi: 10.1016/j.ejca.2020.11.005. Epub 2020 Dec 8. Eur J Cancer. 2021. PMID: 33307492 Free article.

8

The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer.

Jacob S, Davis AA, Gerratana L, Velimirovic M, Shah AN, Wehbe F, Katam N, Zhang Q, Flaum L, Siziopikou KP, Platanias LC, Gradishar WJ, Behdad A, Bardia A, Cristofanilli M. Jacob S, et al. Among authors: davis aa. Clin Cancer Res. 2021 Mar 1;27(5):1361-1370. doi: 10.1158/1078-0432.CCR-20-1566. Epub 2020 Dec 15. Clin Cancer Res. 2021. PMID: 33323406

9

Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer.

Shah AN, Carroll KJ, Gerratana L, Lin C, Davis AA, Zhang Q, Jacob S, Finkelman B, Zhang Y, Qiang W, D'Amico P, Reduzzi C, Gradishar WJ, Behdad A, Cristofanilli M. Shah AN, et al. Among authors: davis aa. Breast Cancer Res Treat. 2021 Jun;187(2):397-405. doi: 10.1007/s10549-021-06236-1. Epub 2021 Jun 2. Breast Cancer Res Treat. 2021. PMID: 34076801

10

Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?

Chae YK, Pan A, Davis AA, Raparia K, Mohindra NA, Matsangou M, Giles FJ. Chae YK, et al. Among authors: davis aa. Clin Lung Cancer. 2016 Sep;17(5):350-361. doi: 10.1016/j.cllc.2016.03.011. Epub 2016 Apr 6. Clin Lung Cancer. 2016. PMID: 27137346 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page